ÂÜÀòÂÒÂ×

Julie Waras Brogren (born 1972) has extensive experience in life science leadership roles in finance, global product launches, and general management. She was previously President of BresoTEC, a Canada HealthTech and has held various leadership positions at Novo Nordisk in Latin America and in global teams, including as head of the Global Launch Office for the Victoza GLP-1 and degludec insulin. Julie Waras Brogren also has experience as a Board member of life science companies. Julie Waras Brogren started her career at Accenture.